Literature DB >> 6114691

Protection against enteric colibacillosis in pigs suckling orally vaccinated dams: evidence for pili as protective antigens.

H W Moon.   

Abstract

Pregnant gilts were vaccinated orally with Escherichia coli that produced pilus antigens K99 or 987P. The vaccines were live or dead enterotoxigenic E coli (ETEC) or a liver rough non-ETEC strain which has little ability to colonize pig intestine. Pigs born to the gilts were challenge exposed orally with K99+ or 987P+ ETEC, which did not produce heat-labile enterotoxin or flagella and which produced somatic and capsular antigens different from those of the vaccine strains. Control gilts had low titers of serum and colostral antibodies against pilus antigens, and their suckling pigs frequently had fatal diarrhea after challenge exposure. Serum antibody titers against pilus antigens of the vaccine strains increased in the gilts after vaccination with liver ETEC, and the colostral antibody titers of these gilts were higher than those of controls. Pigs suckling such vaccinated gilts were more resistant than controls to challenge strains were of different pilus types, and it could not be attributed to enterotoxin neutralization by colostrum. In contrast to the live ETEC vaccines given to the pregnant gilts, the liver rough non-ETEC and dead ETEC vaccines stimulated little or no production of antibody against pilu, and the pigs born of these vaccinated gilts remained highly susceptible to challenge exposure. The results support the hypothesis that pilu can be protective antigens in oral ETEC vaccines. It was indicated that in the system reported, protection depended on living bacteria for the production of pilus antigens in vivo or for the transport of pilus antigens across intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114691

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  10 in total

1.  Passive protection of suckling infant mice against F41-positive enterotoxigenic Escherichia coli strains by intravenous inoculation of the dams with monoclonal antibodies against F41.

Authors:  M Duchet-Suchaux; P Menanteau; F G van Zijderveld
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Neonatal diarrhea of pigs in Quebec: infectious causes of significant outbreaks.

Authors:  M Morin; D Turgeon; J Jolette; Y Robinson; J B Phaneuf; R Sauvageau; M Beauregard; E Teuscher; R Higgins; S Larivière
Journal:  Can J Comp Med       Date:  1983-01

3.  Capsule reduces adherence of enterotoxigenic Escherichia coli to isolated intestinal epithelial cells of pigs.

Authors:  P L Runnels; H W Moon
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

4.  Type 1 pili (F1) of porcine enterotoxigenic Escherichia coli: vaccine trial and tests for production in the small intestine during disease.

Authors:  S C To; H W Moon; P L Runnels
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

5.  Immunization of swine with heat-stable Escherichia coli enterotoxin coupled to a carrier protein does not protect suckling pigs against an Escherichia coli strain that produces heat-stable enterotoxin.

Authors:  H W Moon; A L Baetz; R A Giannella
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.

Authors:  Xiaosai Ruan; Mei Liu; Thomas A Casey; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

7.  Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.

Authors:  C O Jacob; R Arnon; R A Finkelstein
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine.

Authors:  F A Klipstein; R F Engert; J D Clements; R A Houghten
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  F41 pili as protective antigens of enterotoxigenic Escherichia coli that produce F41, K99, or both pilus antigens.

Authors:  P L Runnels; S L Moseley; H W Moon
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

Review 10.  Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals.

Authors:  H W Moon; T O Bunn
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.